113 related articles for article (PubMed ID: 22044821)
21. Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.
Tesfa D; Palmblad J
Expert Rev Hematol; 2011 Dec; 4(6):619-25. PubMed ID: 22077526
[TBL] [Abstract][Full Text] [Related]
22. Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection.
Watanabe M; Shibuya A; Tsunoda Y; Danbara M; Ishii R; Ohsaka M; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Horie R; Higashihara M; Koizumi W
Liver Int; 2011 Mar; 31(3):340-7. PubMed ID: 21134110
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus meningoencephalitis after rituximab treatment for primary central nervous system lymphoma.
Siakantaris MP; Argyropoulos KV; Ioannou S; Papadopoulou V; Tzeletas G; Tsonis J; Dimitrakopoulou A; Yiannopoulou KG; Pangalis GA; Vaiopoulos G
Neurologist; 2015 Jan; 19(2):35-7. PubMed ID: 25607329
[TBL] [Abstract][Full Text] [Related]
24. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
[No Abstract] [Full Text] [Related]
25. Enterovirus 71 meningoencephalitis complicating rituximab therapy.
Ahmed R; Buckland M; Davies L; Halmagyi GM; Rogers SL; Oberste S; Barnett MH
J Neurol Sci; 2011 Jun; 305(1-2):149-51. PubMed ID: 21444094
[TBL] [Abstract][Full Text] [Related]
26. [Acute lung injury in a patient with concurrent diffuse large B-cell lymphoma and myelodysplastic syndrome].
Tokuyama T; Muta T; Yasunaga M; Nakanishi H; Ueda Y; Fujisaki T
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1733-7. PubMed ID: 21996978
[TBL] [Abstract][Full Text] [Related]
27. Primary central nervous system lymphoma with testicular metastasis.
Liu XJ; Zhao JZ; Li G; Ye X; Yan PX
Clin Neurol Neurosurg; 2012 Jan; 114(1):80-3. PubMed ID: 21871714
[No Abstract] [Full Text] [Related]
28. [Cerebral infarction and myocardial infarction due to cisplatin-containing chemotherapy].
Brouha ME; Bloemendal HJ; Kappelle LJ; Winter JB
Ned Tijdschr Geneeskd; 2003 Mar; 147(10):457-60. PubMed ID: 12666519
[TBL] [Abstract][Full Text] [Related]
29. Prolonged hypogammaglobulinemia after adjuvant rituximab for Hodgkin's lymphoma presenting with refractory urticaria.
Wolverton W; McClenathan B
Ann Allergy Asthma Immunol; 2012 Dec; 109(6):473-4. PubMed ID: 23176893
[No Abstract] [Full Text] [Related]
30. Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphoma.
Pohlen M; Gerth HU; Liersch R; Koschmieder S; Mesters RM; Kessler T; Appelmann I; Müller-Tidow C; Berdel WE
Am J Hematol; 2011 Dec; 86(12):E61-4. PubMed ID: 21898532
[TBL] [Abstract][Full Text] [Related]
31. Rapid development of infusion-related severe hypotension during rituximab therapy.
Vo KH; Waddell JA; Suda KJ
Ann Pharmacother; 2011 May; 45(5):e29. PubMed ID: 21505107
[TBL] [Abstract][Full Text] [Related]
32. Rituximab maintenance therapy for follicular lymphoma: no better than watchful waiting.
Prescrire Int; 2012 Mar; 21(125):62. PubMed ID: 22428182
[TBL] [Abstract][Full Text] [Related]
33. [A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Shi YK; Yang S; Han XH; Ma J; Ren HY; Cen XN; Zhou SY; Wang C; Jiang WQ; Huang HQ; Wang JM; Zhu J; Chen H; Han MZ; Huang H; Shen XM; Liu P; He XH
Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):592-6. PubMed ID: 20021946
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications.
Zoltick BH; Jacobs LA; Vaughn DJ
Oncol Nurs Forum; 2005 Sep; 32(5):1005-9; quiz 1010-1. PubMed ID: 16136198
[TBL] [Abstract][Full Text] [Related]
35. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).
Kang HJ; Lee SS; Kim KM; Choi TH; Cheon GJ; Kim WS; Suh C; Yang SH; Lim SM
Asia Pac J Clin Oncol; 2011 Jun; 7(2):136-45. PubMed ID: 21585693
[TBL] [Abstract][Full Text] [Related]
37. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
38. [Hepatitis B reactivation with rituximab in an HIV-infected anti-HBs antibody carrier].
Benghalia K; Roussin-Bretagne S; Marque-Juillet S; Colardelle P; Chochon M; Harzic M; Doll J
Med Mal Infect; 2011 Aug; 41(8):437-9. PubMed ID: 21700407
[No Abstract] [Full Text] [Related]
39. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
Cha SI; Choi KJ; Shin KM; Lim J; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
Respiration; 2013; 85(2):175. PubMed ID: 23234874
[No Abstract] [Full Text] [Related]
40. Interstitial pneumonitis related to rituximab therapy.
Burton C; Kaczmarski R; Jan-Mohamed R
N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
